Pharmacology

Fibrates for MI Risk in Metabolic Syndrome

Fed Pract. 2005 September;22(9):32
PDF Download

 

Recommended Reading

Reducing Wait Times for Cardiac Consultation
Federal Practitioner
Comparing Effects of Daily and Twice Weekly Simvastatin
Federal Practitioner
Rosiglitazone to Prevent Restenosis
Federal Practitioner
Effects of Statins in Type 2 Diabetes
Federal Practitioner
Disparity Between CVD Risk and Mortality?
Federal Practitioner
Post-PCI Fluvastatin for Diabetics
Federal Practitioner
Thrombosis in Drug-Eluting Stents
Federal Practitioner
Risks of AMI in RA
Federal Practitioner
Using Transesophageal Echocardiography to Guide Early Cardioversion
Federal Practitioner
Erythromycin and Sudden Cardiac Death
Federal Practitioner